Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TBE Vaccination in Allogeneic HSCT Recipients
NCT01991067Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Jul 2014
- Primary completion
- Oct 2018
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of FSME-IMMUN in tick-borne encephalitis (TBE), sponsored by Medical University of Vienna. Started Jul 2014; status: completed.
02
Drugs
FSME-IMMUN
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on NCT01991067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01991067.